Table 2 Baseline data of participants who completed at least one dietary period reported by sequence
|
Intervention-Control n = 25 n (%) |
Control-Intervention n = 22 n (%) |
All n = 47 n (%) | |
|---|---|---|---|
| Demographics | |||
| Female | 20 (80) | 16 (73) | 36 (77) |
| Smokers | 2 (8) | 0 (0) | 2 (4.3) |
| Origin of parents | |||
| Europe | 23 (92) | 21 (95) | 44 (94) |
| Africa | 1 (4) | 0 (0) | 1 (2) |
| Asia | 1 (4) | 1 (5) | 2 (4) |
| Education | |||
| Junior high school | 4 (16) | 4 (18) | 8 (17) |
| 2 year senior high school | 4 (16) | 5 (23) | 9 (19) |
| ≥ 3 year senior high school | 3 (12) | 4 (18) | 7 (15) |
| College or university | 14 (56) | 9 (41) | 23 (49) |
| Everyday physical activity | |||
| Sedentary or standing | 5 (20) | 1 (4.5) | 6 (13) |
| Light but partly physically active | 12 (48) | 4 (18) | 16 (34) |
| Light and physically active | 6 (24) | 9 (41) | 15 (32) |
| Sometimes physically straining | 2 (8.0) | 8 (36) | 10 (21) |
| Training in exercise outfit, past 3-months | |||
| Never | 2 (8.0) | 5 (23) | 7 (15) |
| Every now and then – not regularly | 8 (32) | 6 (27) | 14 (30) |
| 1–2 times/week | 7 (28) | 3 (14) | 10 (21) |
| 2–3 times/week | 5 (20) | 4 (18) | 9 (19) |
| > 3 times/week | 3 (12) | 4 (18) | 7 (15) |
| Medications used at baseline | |||
| Cardiovascular agents | 14 (56) | 9 (41) | 23 (49) |
| Vasodilator | 9 (36) | 8 (36) | 17 (36) |
| Statins | 5 (20) | 3 (14) | 8 (17) |
| Betablocker | 5 (20) | 3 (14) | 8 (17) |
| Anticoagulants | 1 (4) | 3 (14) | 4 (9) |
| Diuretics | 3 (12) | 2 (9) | 5 (11) |
| bDMARD | 8 (32) | 10 (45) | 18 (38) |
| csDMARD | 19 (76) | 16 (73) | 35 (74) |